News

Filter by year:

Filter by tags:

3/07/2019

Penn’s Gene Therapy Vector Core Receives $13 Million, Five-Year Renewal from NIH

Virus-Based Program Supports Advancement of Translational, Gene-Therapy Research

2/26/2019

Amicus Establishes Global Research and Gene Therapy Center of Excellence in Philadelphia

"...Amicus is working to pioneer significant advancements in gene therapy, which includes a collaboration with Dr. James Wilson and his team at our Orphan Disease Center. This relationship reflects how the innovation ecosystem at Penn brings together researchers, innovators, and entrepreneurs to accelerate research discoveries to patients as quickly as possible..." -Dr Larry Jameson, Executive Vice President for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine

2/24/2019

Christian Can See

Scientific pioneers Dr Jim Wilson, Dr Jean Bennett, and Dr Kathy High discuss their extraordinary research and the promise of gene therapy in an interview with former Speaker of the House Newt Gingrich.

2/14/2019

Passage Bio Launches with $115.5 Million Series A to Develop AAV-Delivered Therapeutics to Treat Rare Monogenic CNS Diseases

Industry veterans Stephen Squinto, Ph.D. and Tachi Yamada, M.D. team up with gene therapy pioneer James Wilson, M.D., Ph.D. to launch new world-class CNS-focused gene therapy company

12/05/2018

Sanford Lorraine Cross Nominee: Jim Wilson

11/06/2018

Multidomain Antibody to Neutralize Flu Virus Through Entire Season

Drs James Wilson and Maria Limberis from the Gene Therapy Program collaborated on this study and discovered that this approach could offer protection against multiple strains of influenza.